INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 09/15/20
Evolus Shareholder Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Evolus, Inc. To Contact The FirmNewsfile Corp • 09/13/20
INVESTOR ALERT: Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Evolus, Inc.Business Wire • 09/11/20
Evolus Shareholder Notice: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Evolus, Inc. To Contact The FirmNewsfile Corp • 09/11/20
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Evolus, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 09/09/20
5 Red-Hot Biotech and Medtech Stocks Under $10 With Massive Upside Potential24/7 Wall Street • 08/15/20
Evolus Inc. (EOLS) CEO David Moatazedi on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/11/20
Evolus to Report Second Quarter 2020 Financial Results and Provide a Business Update on Monday, August 10, 2020GlobeNewsWire • 07/27/20
Evolus Provides Update on United States International Trade Commission (USITC) CaseGlobeNewsWire • 07/06/20
Evolus' (EOLS) CEO David Moatazedi on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/12/20
Evolus, Inc. (EOLS) CEO David Moatazedi on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/25/20
Positive Results from Phase III, Split-Face, Head-to-Head Study Comparing OnabotulinumtoxinA and PrabotulinumtoxinA in the Treatment of Crow’s Feet Lines Published in Dermatologic SurgeryGlobeNewsWire • 01/27/20
Evolus, Inc. (EOLS) CEO David Moatazedi on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/04/19
Evolus and Clarion Medical Technologies Announce First Shipment of Nuceiva™ (prabotulinumtoxinA) to Customers in CanadaGlobeNewsWire • 10/16/19